Sustainability + Impact
For more than a decade, Sofinnova Partners has been investing in companies that apply biotechnology to develop sustainable solutions in agriculture, food, chemicals and materials.
We're an environmental impact strategy, with a focus on early-stage investments, helping entrepreneurs build teams and knowledge networks. We find the right financial and industrial partners so that companies we invest in have multiple options.
| Close | Fund | AMT |
|---|---|---|
| 2012 | Sofinnova Green Seed Fund | €22.5 million |
| 2017 | Sofinnova IB I | €125 million |
| 2021 | Sofinnova IB II | €175 million |
Close: 2012
Fund: Sofinnova Green Seed Fund
AMT: €22.5 million
Close: 2017
Fund: Sofinnova IB I
AMT: €125 million
Close: 2021
Fund: Sofinnova IB II
AMT: €175 million
Video: The Industrial Biotech team explains the investment thesis behind their strategy
Industrial biotech is important for Sofinnova Partners because it is critical to our collective future. Each member of the team is motivated by a desire to bring sustainable solutions to our everyday life.
- Sofinnova Industrial BiotechA decade of perfecting an impact strategy
Sofinnova Partners' Industrial Biotech team officially closed the firm's first formal impact fund under Article 9 of the Sustainable Finance Disclosure Regulation (SFDR). Here is our story about how it all started more than a decade ago with the idea that biotechnology was evolving so quickly that it would disrupt sectors outside of healthcare. A team took shape and the idea blossomed through three iterations into a €175 million early-stage fund.
"We could easily live without an Uber. It's not going to change our lives if we just have to flag a taxi. But tomorrow if we run out of food, that's a big problem. If we destroy the environment, that's a big problem."
“Founders need to have force, to be able to move mountains and stay resilient when things are not easy. Creativity and charisma are important, of course, but resilience is a very key feature.”
"If you want to find a deeptech investor, able to make some impact and help you make progress in industrial biotech — Sofinnova is it."
“You need to hire people who are better than you are.”
Companies
Fund iteration
Status
Deal lead
Industrial Biotech
Afyren
Industrial Biotech
Biosyntia
Industrial Biotech
Biotalys
Industrial Biotech
CelluComp
Industrial Biotech
Comet Biorefining
Industrial Biotech
DMC Biotechnologies
Industrial Biotech
DNA Script
Industrial Biotech
Elicit Plant
Industrial Biotech
EnginZyme
Industrial Biotech
GFBiochemicals
Industrial Biotech
Meiogenix
Industrial Biotech
MetGen
Industrial Biotech
Micropep Technologies
Industrial Biotech
Microphyt
Industrial Biotech
Prometheus Materials
Industrial Biotech
Protera
Industrial Biotech
Pyrowave
Crossover & Industrial Biotech
Synthace
0 results
Related News
AFYREN inaugurates its first factory, AFYREN NEOXY, a first-of-its-kind biorefinery
Synthace appoints Dr. Donald Deieso as new Board Chair
Micropep, ag-biotech innovator, raises €8.75 million from global syndicate to bring ground-breaking and cost-effective alternatives to conventional crop protection products to market
Biosyntia closes a €11.5 million round to launch world’s first bio-based vitamin B7
Skidmore, Owings & Merrill partners with Prometheus Materials to design zero-carbon building material